Stifel

M&K Legacy Wealth Brings $1 Billion in Client Assets to Sanctuary Wealth

Retrieved on: 
星期五, 三月 8, 2024
Freedom, Sanctuary, Stifel, Culture, CRPC, Retirement, CFA, APMA, Partner, Financial adviser

INDIANAPOLIS, March 8, 2024 /PRNewswire/ -- Sanctuary Wealth (Sanctuary), home to the next generation of elite advisors, welcomes M&K Legacy Wealth (M&K) the latest breakaway to launch their own firm with Sanctuary's Partnered Independence platform. With $1 billion in total client assets, Indianapolis-based M&K was formerly known as Tanner Wealth Management Group and employed by Stifel.

Key Points: 
  • INDIANAPOLIS, March 8, 2024 /PRNewswire/ -- Sanctuary Wealth (Sanctuary), home to the next generation of elite advisors, welcomes M&K Legacy Wealth (M&K) the latest breakaway to launch their own firm with Sanctuary's Partnered Independence platform.
  • With $1 billion in total client assets, Indianapolis-based M&K was formerly known as Tanner Wealth Management Group and employed by Stifel.
  • Vince Fertitta, President, Sanctuary Wealth said, "Being introduced to great teams like M&K by our existing Partner Firms is the best compliment Sanctuary can receive.
  • Adam Malamed, CEO, Sanctuary Wealth, concluded, "J.,Chad and their entire team are the perfect fit for our business model and culture, and we are thrilled to welcome them to the Sanctuary Wealth family.

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock

Retrieved on: 
星期四, 二月 29, 2024
Varick Street, Attention, SAN, Truist, Prospectus, Telephone, Stifel, File, 2nd Floor, Sale, Vikings, Form, State Street, SVB Securities, Therapy, Morgan Stanley, S-3, Security (finance), Oppenheimer Holdings

SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000 shares of its common stock at a price to the public of $85.00 per share.

Key Points: 
  • SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its  underwritten public offering of 6,471,000 shares of its common stock at a price to the public of $85.00 per share.
  • The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $550.0 million.
  • Viking has also granted the underwriters a 30-day option to purchase up to 970,650 additional shares of its common stock.
  • All of the shares of common stock in the offering are to be sold by Viking.

Viking Therapeutics Announces Proposed Public Offering of Common Stock

Retrieved on: 
星期二, 二月 27, 2024
Varick Street, Attention, SAN, Truist, Prospectus, Telephone, Stifel, File, 2nd Floor, Sale, Vikings, Form, State Street, SVB Securities, Therapy, Morgan Stanley, S-3, Security (finance), Research, Life insurance

SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it has commenced an underwritten public offering of $350.0 million of shares of its common stock.

Key Points: 
  • SAN DIEGO, Feb. 27, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it has commenced an underwritten public offering of $350.0 million of shares of its common stock.
  • Viking also intends to grant the underwriters a 30-day option to purchase up to an additional $52.5 million of shares of its common stock.
  • All of the shares of common stock to be sold in the proposed offering are to be sold by Viking.
  • The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.

Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions

Retrieved on: 
星期三, 二月 21, 2024
Acquisition, Stifel, Growth, Sale, Entrepreneurship, Consultant, Health, Fatigue, Conversion, Employment, LLP, Security (finance)

NEW YORK, Feb. 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company") announced today that it has acquired Twill, Inc. ("Twill"), a leader in digital-led care. The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions. The transaction creates immediate scale, with three of the top eight national health plans, multiple Fortune 100 employers and several major pharmaceutical companies as customers.

Key Points: 
  • The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions.
  • "The Twill acquisition is an incredible opportunity to bring together our complementary solutions and create an unrivaled platform for the next generation of consumer-centric digital health.
  • The addition of Twill instantly boosts revenue and margins, leveraging a robust SaaS-like model to fuel expected rapid growth and accelerating profitability.
  • TD Cowen acted as financial advisor, and Lowenstein Sandler LLP acted as legal counsel, to Twill in connection with the transaction.

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

Retrieved on: 
星期三, 二月 14, 2024
Acquisition, Jefferies Group, Stifel, Form, Arrhythmia, Reed Smith, Kirkland & Ellis, Atrial fibrillation, Patient, Tachycardia, LLP, White & Case, Catheter ablation, Investment, PFCA, Security (finance)

LAGUNA HILLS, Calif., Feb. 14, 2024 /PRNewswire/ -- Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, and ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) ("ARYA"), a special purpose acquisition company that is sponsored by an affiliate of Perceptive Advisors, LLC ("Perceptive Advisors"), today announced they have entered a definitive agreement (the "business combination agreement") for a business combination (the "transaction"). Upon closing of the transaction, Adagio Medical will become a subsidiary of Aja Holdco, Inc. (the "Combined Company"), which will operate with the existing Adagio Medical management team under the name "Adagio Medical, Inc." The Combined Company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ADGM".

Key Points: 
  • Investors in the financing include affiliates of Perceptive Advisors, RA Capital Management ("RA Capital"), RTW Investments and ATW Partners.
  • "In Adagio Medical, we've come to believe that the company's innovative cardiac ablation technology, thoughtful commercialization strategy, and experienced leadership team make it an exceptional fit to meet our objectives."
  • The respective boards of directors of both ARYA and Adagio Medical have approved the proposed transaction.
  • Jefferies LLC ("Jefferies") is acting as financial and capital markets advisor to ARYA, as well as sole private placement agent.

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

Retrieved on: 
星期三, 二月 14, 2024
Acquisition, Jefferies Group, Stifel, Form, Arrhythmia, Reed Smith, Kirkland & Ellis, Atrial fibrillation, Patient, Tachycardia, LLP, White & Case, Catheter ablation, Investment, PFCA, Security (finance)

LAGUNA HILLS, Calif., Feb. 14, 2024 /PRNewswire/ -- Adagio Medical, Inc. ("Adagio Medical"), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, and ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) ("ARYA"), a special purpose acquisition company that is sponsored by an affiliate of Perceptive Advisors, LLC ("Perceptive Advisors"), today announced they have entered a definitive agreement (the "business combination agreement") for a business combination (the "transaction"). Upon closing of the transaction, Adagio Medical will become a subsidiary of Aja Holdco, Inc. (the "Combined Company"), which will operate with the existing Adagio Medical management team under the name "Adagio Medical, Inc." The Combined Company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ADGM".

Key Points: 
  • Investors in the financing include affiliates of Perceptive Advisors, RA Capital Management ("RA Capital"), RTW Investments and ATW Partners.
  • "In Adagio Medical, we've come to believe that the company's innovative cardiac ablation technology, thoughtful commercialization strategy, and experienced leadership team make it an exceptional fit to meet our objectives."
  • The respective boards of directors of both ARYA and Adagio Medical have approved the proposed transaction.
  • Jefferies LLC ("Jefferies") is acting as financial and capital markets advisor to ARYA, as well as sole private placement agent.

D-BOX Technologies Reports Fiscal 2024 Third Quarter Results

Retrieved on: 
星期二, 二月 13, 2024
Stifel, Marketing, Water, Growth, Sale, Calendar, Disclosure, Chairperson, MD&A, Bank statement, Research, Depreciation, Film industry

MONTREAL, Feb. 13, 2024 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (“D-BOX” or the "Corporation") (TSX: DBO) a world leader in haptic and immersive experiences, today reported financial results for the third quarter ended December 31, 2023. All dollar amounts are expressed in Canadian currency.

Key Points: 
  • During the quarter, there were 19 net new screen installations in the theatrical business compared to 27 for the same period last year.
  • Operating expenses for the quarter were $4.0 million, or 50% of revenues, compared to $4.6 million, or 44% of revenues, in the same quarter a year earlier.
  • Net loss for the quarter was $425 thousand compared with a net loss of $110 thousand a year earlier.
  • During the presentation, management will discuss the Corporation’s third quarter results and outlook for the balance of the fiscal year.

Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

Retrieved on: 
星期二, 二月 13, 2024
Acquisition, Stifel, Sale, Kirkland & Ellis, United States bankruptcy court, Bankruptcy Code, Berkeley Research Group, Bankruptcy

The Company further disclosed that it intends to pursue a sale of its business under Section 363 of the Bankruptcy Code, while continuing to support its customers during the Chapter 11 process.

Key Points: 
  • The Company further disclosed that it intends to pursue a sale of its business under Section 363 of the Bankruptcy Code, while continuing to support its customers during the Chapter 11 process.
  • The Company seeks to execute an expedited sale process.
  • Sientra will utilize existing cash reserves and $22.5 million in new money debtor-in-possession financing from existing lenders to facilitate the sale and support ongoing Company operations.
  • The Company will continue to operate its business during this process.

Arevon and Blackstone Credit & Insurance Close $350 Million Preferred Equity, Debt, and ITC Transfer Financing for Condor Energy Storage Project

Retrieved on: 
星期二, 二月 13, 2024
Engineering, Project finance, Blackstone Credit, Senior, EVP, Climate, Stifel, Winston & Strawn, CoBank, Bank, Condor, Andrew Downey Orrick, HASI, ACB, Sumitomo Mitsui Banking Corporation, Collateral, Partner, EPC, BNY Mellon, Partnership, Renewable energy

NEW YORK and SCOTTSDALE, Ariz., Feb. 13, 2024 /PRNewswire/ -- Arevon Energy, Inc., a leading renewable energy developer, owner, and operator, together with Blackstone Credit & Insurance (BXCI), today announced a successful financial close for the 200 megawatt/800 megawatt-hour Condor Energy Storage Project (Condor) currently under construction in Grand Terrace, California.

Key Points: 
  • The project will be capable of providing firming capacity, enhancing grid reliability and stability alongside increased adoption of renewable energy resources.
  • Blackstone's preferred equity investment in Condor is structured to simplify the monetization of tax credits, eliminating the need for traditional tax equity financing.
  • Zachary Rubenstein, Managing Director in the Blackstone Credit & Insurance Sustainable Resources Group, commented "Arevon is a world-class renewable energy company, and we are excited to be their partner on the Condor financing.
  • Arevon secured real estate financing from climate investment firm HASI related to the Condor Energy Storage Project land.

Interstate Waste Services Announces Acquisition of Oak Ridge Waste & Recycling

Retrieved on: 
星期一, 二月 12, 2024
Acquisition, Collection, Equity (finance), Littlejohn, Haulage, Stifel, Culture, Growth, Littlejohn & Co., Kirkland & Ellis, Organization, ARES, Recycling, Workforce

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Interstate Waste Services, Inc. ("IWS"), a leading, vertically integrated waste-by-rail provider of solid waste collection, disposal and recycling services announced it has entered into a definitive agreement to acquire Oak Ridge Waste & Recycling ("Oak Ridge"), one of Connecticut's preeminent providers of waste collection, transfer, and recycling services in Southwestern Connecticut and Suburban New York, further expanding IWS's service footprint into the tristate area.

Key Points: 
  • NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Interstate Waste Services, Inc. ("IWS"), a leading, vertically integrated waste-by-rail provider of solid waste collection, disposal and recycling services announced it has entered into a definitive agreement to acquire Oak Ridge Waste & Recycling ("Oak Ridge"), one of Connecticut's preeminent providers of waste collection, transfer, and recycling services in Southwestern Connecticut and Suburban New York, further expanding IWS's service footprint into the tristate area.
  • The acquisition comes on the heels of IWS subsidiary Action Environmental's selection as an authorized waste and recycling hauler under New York City's Commercial Waste Hauling Program, Local Law 199 .
  • "Oak Ridge has an established presence in an attractive adjacent market delivering collection and processing services through a dedicated workforce and an entrenched culture that fits exceptionally well with IWS," said Michael DiBella Chief Executive Officer of Interstate Waste Services.
  • Stifel served as financial advisor to Oak Ridge Waste & Recycling, and Whiteman Osterman & Hanna served as legal counsel.